Advertisement
Screener

LIQUIDIA CORPORATION (LQDA) ROE

LIQUIDIA CORPORATION (LQDA) ROE

  • 2026-06-30: ROE 71.04%.
  • 2026-03-31: ROE 20.54%.
  • 2025-12-31: ROE -154.03%.
  • 2025-09-30: ROE -553.19%.

Complete source-backed roe history.

Available history
2019-12-31 to 2026-06-30
Data captured

Historical ROE

DateROE
2026-06-3071.04%
2026-03-3120.54%
2025-12-31-154.03%
2025-09-30-553.19%
2025-06-30-984.17%
2025-03-31-274.73%
2024-12-31-161.62%
2024-09-30-103.96%
2024-06-30-140.02%
2024-03-31-99.73%
2023-12-31-165.99%
2023-09-30-119.95%
2023-06-30-83.89%
2023-03-31-45.10%
2022-12-31-45.36%
2022-09-30-48.45%
2022-06-30-43.32%
2022-03-31-74.63%
2021-12-31-52.98%
2021-09-30-53.59%
2021-06-30-59.21%
2021-03-31-86.08%
2020-12-31-84.07%

Annual ROE

DateROE
2025-12-31-154.03%
2024-12-31-161.62%
2023-12-31-165.99%
2022-12-31-45.36%
2021-12-31-52.98%
2020-12-31-84.07%
2019-12-31-136.16%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Amneal Pharmaceuticals, Inc. (AMRX)$6.326B25.62
RHYTHM PHARMACEUTICALS, INC. (RYTM)United States$6.771B-37.20
Alkermes plc. (ALKS)$6.844B132.74
Mirum Pharmaceuticals, Inc. (MIRM)United States$5.798B-8.81
Travere Therapeutics, Inc. (TVTX)United States$5.712B-123.10
Oruka Therapeutics, Inc. (ORKA)United States$5.663B-43.76
Cogent Biosciences, Inc. (COGT)United States$5.450B-17.61
IONIS PHARMACEUTICALS INC (IONS)United States$7.277B-23.25
Gossamer Bio, Inc. (GOSS)United States$5.355B-0.65
PTC THERAPEUTICS, INC. (PTCT)United States$5.199B-177.07